VOL. XCIV, NO. 247
* WIDE MOAT STOCKS COMPARISON *
NO ADVICE
Monday, December 29, 2025
Stock Comparison
Anheuser-Busch InBev SA/NV vs GSK plc
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Anheuser-Busch InBev SA/NV
ABI · Euronext Brussels
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Anheuser-Busch InBev SA/NV's moat claims, evidence, and risks.
View ABI analysisGSK plc
GSK · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Anheuser-Busch InBev SA/NV leads (75 / 100 vs 62 / 100 for GSK plc).
- Segment focus: Anheuser-Busch InBev SA/NV has 6 segments (28.6% in Middle Americas); GSK plc has 3 segments (37.6% in Specialty Medicines).
- Primary market structure: Duopoly vs Oligopoly. Pricing power: Moderate vs Strong.
- Moat breadth: Anheuser-Busch InBev SA/NV has 5 moat types across 3 domains; GSK plc has 4 across 3.
Primary market context
Anheuser-Busch InBev SA/NV
Middle Americas
Beer and malt-based beverages (plus growing no-alcohol and Beyond Beer)
Mexico, Central America, and Caribbean (AB InBev reporting segment)
Retailers and on-premise outlets
Brewer / brand owner + route-to-market operator
28.6%
GSK plc
Specialty Medicines
Branded specialty pharmaceuticals (HIV, oncology, immunology/respiratory)
Global
Hospitals, specialist physicians, payers
Innovator & branded manufacturer
37.6%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Anheuser-Busch InBev SA/NV strengths
GSK plc strengths
Segment mix
Anheuser-Busch InBev SA/NV segments
Full profile >North America
Oligopoly
Middle Americas
Duopoly
South America
Oligopoly
EMEA
Oligopoly
Asia Pacific
Competitive
Global Export & Holding Companies
Competitive
GSK plc segments
Full profile >Vaccines
Oligopoly
Specialty Medicines
Oligopoly
General Medicines
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.